The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 01, 2020
Filed:
Mar. 15, 2019
Applicant:
The Regents of the University of California, Oakland, CA (US);
Inventors:
Carl W. Cotman, Santa Ana, CA (US);
Larry E. Overman, Corona del Mar, CA (US);
Shikha Snigdha, Long Beach, CA (US);
Assignee:
REGENTS OF THE UNIVERSITY OF CALIFORNIA, Oakland, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/548 (2006.01); A61P 25/28 (2006.01); A61K 31/473 (2006.01); A61K 31/445 (2006.01); A61K 31/27 (2006.01); A61P 25/00 (2006.01); A61K 31/522 (2006.01); A61K 31/202 (2006.01); A61P 25/22 (2006.01); C07D 513/18 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/548 (2013.01); A61K 31/202 (2013.01); A61K 31/27 (2013.01); A61K 31/445 (2013.01); A61K 31/473 (2013.01); A61K 31/522 (2013.01); A61K 45/06 (2013.01); A61P 25/00 (2018.01); A61P 25/22 (2018.01); A61P 25/28 (2018.01); C07D 513/18 (2013.01);
Abstract
Use of H3K9me3 modulation for enhancing cognitive function and treating anxiety related disorders is presented. A composition is administered to the subject comprising a therapeutically effective amount of a SUV39H1 inhibitor comprising analogs of ETP69. The therapeutically effective amount is effective in treating cognitive dysfunction in aging and age-related disorders.